Repaglinide: all 43 studies that test it

Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.RecruitingNCT07372625Phase 1
• A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced MalignanciesRecruitingNCT07340190Phase 1
• A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.Not yet recruitingNCT06601517Phase 1
• A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the BodyCompletedNCT06494761Phase 1Results posted
• A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the BloodCompletedNCT06367153Phase 1Results posted
• A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy ParticipantsCompletedNCT06165146Phase 1Results posted
• A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)CompletedNCT01709305Phase 4Results posted
• Effect of BIA 9-1067 on the Pharmacokinetics of RepaglinideCompletedNCT01536366Phase 1Results posted
• Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug TreatmentCompletedNCT01022762Phase 4Results posted
• Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic FibrosisCompletedNCT00763412Not applicableResults posted
• Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult ParticipantsCompletedNCT07235748Phase 1
• A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy ParticipantsCompletedNCT06948747Phase 1
• A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy ParticipantsCompletedNCT06503679Phase 1
• A Study of the Interaction of Other Drugs With TAK-279 in Healthy AdultsCompletedNCT06290050Phase 1
• PK Effects of SHR4640 on Repaglinide and Midazolam, and the Impact of SHR4640 on QT IntervalCompletedNCT06196580Phase 1
• Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and DolutegravirCompletedNCT05236530Phase 1
• Drug-drug Interaction of SHR3680 With Repaglinide and BupropionStatus unknownNCT04664725Phase 1
• A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GISTCompletedNCT04530981Phase 1
• A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor SubjectsCompletedNCT04457180Phase 1
• Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyCompletedNCT03359837Phase 4
• The Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion in Healthy Male VolunteersCompletedNCT02305901Phase 1
• A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and CaffeineCompletedNCT02128321Phase 1
• Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in ChinaCompletedNCT02040246Phase 4
• A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy SubjectsCompletedNCT01797198Phase 1
• Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 DiabetesCompletedNCT01720303Phase 4
• Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 DiabetesCompletedNCT01720290Phase 4
• Efficacy of Repaglinide in Subjects With Type 2 DiabetesCompletedNCT01698931Phase 4
• Effect of Repaglinide on Postprandial Lipemia in Type 2 DiabetesCompletedNCT01605773Phase 4
• Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 DiabetesCompletedNCT01562561Phase 3
• Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy VolunteersCompletedNCT01490658Phase 1
• Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy VolunteersCompletedNCT01489644Phase 1
• Treatment of Latent Autoimmune Diabetes of the AdultCompletedNCT01140438Not applicable
• Comparison of the Effects of Repaglinide and Metformin on Glucose ExcursionsStatus unknownNCT00832481Not applicable
• Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 DiabetesTerminatedNCT00799448Phase 4
• Early Diagnosis of Diabetes Mellitus in Patients With Cystic FibrosisCompletedNCT00662714Phase 3
• Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 DiabetesCompletedNCT00568984Phase 4
• Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 DiabetesCompletedNCT00568074Phase 4
• Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic DrugsCompletedNCT00491725Phase 4
• Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 DiabetesCompletedNCT00451620Phase 2
• A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus PatientsStatus unknownNCT00336310Phase 4
• Repaglinide for Adolescents With Cystic Fibrosis-Related DiabetesWithdrawnNCT00231192Not applicable
• Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-DiabetesCompletedNCT00118963Phase 4
• Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by DietCompletedNCT00118950Phase 4

← Repaglinide overview